AzTrials
AzTrials

Thoracic Outlet SyndromeNCT06992752

Dysfunctional Breathing in Individuals With Thoracic Outlet Syndrome

An observational study of Thoracic Outlet Syndrome, run by Hacettepe University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this observational study was to learn about the characteristics of dysfunctional breathing in individuals with thoracic outlet syndrome. The main question to be answered is: Is there a dysfunctional breathing pattern in individuals with Thoracic outlet syndrome? These features will be compared with a… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Thoracic Outlet Syndrome
How many people
54 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Feb 2025to 2 Oct 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: In the study, adult patients aged between 18-65 years who were diagnosed with TOS by a thoracic surgeon at the Cardiopulmonary Rehabilitation Unit of the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, and who had pain complaints for more than 6 months without surgery will be evaluated. Control cases planned to be included in the study to compare with the results of the patients will be formed by using the snowball method from the immediate environment.

Who may be able to join

  • To agree to participate in the study,
  • To have been diagnosed with TOS by a thoracic surgeon,
  • To be between 18-65 years old,
  • Having pain for more than 6 months

Who cannot join

  • Patients with a history of spinal or thoracic surgery for TOS or any other reason,
  • People with traumatic cervical injury,
  • Severely obese people (BMI >40 kg/m2),
  • People with clinical abnormalities in the thoracic cage or vertebral column,
  • Persons with occupational industrial exposures,
  • Patients with severe comorbidities (neurological, neuromuscular, -cardiorespiratory, psychiatric and musculoskeletal) diabetes mellitus and/or malignancies

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Melda Sağlam, Professor contact

+903123052525 ext. 146

msaglam@hacettepe.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Hacettepe University

    Ankara, Altındağ, 06100

    Melda Sağlam, Professor, +903123052525 ext. 146, msaglam@hacettepe.edu.tr

    Ebru Çalık Kütükcü, Professor, +903122525 ext. 195, ebrucalik@hacettepe.edu.tr

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Properties of Dysfunctional Breathing in Individuals With Thoracic Outlet Syndrome

The aim of this observational study was to learn about the characteristics of dysfunctional breathing in individuals with thoracic outlet syndrome. The main question to be answered is:

Is there a dysfunctional breathing pattern in individuals with Thoracic outlet syndrome? These features will be compared with a healthy control group to evaluate the association of Thoracic outlet syndrome with dysfunctional breathing

Keywords
Thoracic Outlet Syndrome, Dysfunctional Breathing
Medical subject headings
Thoracic Outlet Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06992752
Study groupRoleWhat they receive
Thoracic Outlet SyndromeThoracic Outlet Syndrome
Healthy controlHealthy control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nijmegen Questionnaire

    A cut-off score of ≥20 in Nijmegen will be used to define dysfunctional breathing. The minimum score is 0 and the maximum score is 60 points. Higher scores mean worse outcome.

    Measured: Day 1

  2. End tidal CO2

    A standard value of <35 mmHg will be used as the cut-off point for dysfunction

    Measured: Day 1

  3. Manual Assessment of Respiratory Motion

    This technique is used to assess and measure the distribution of respiratory movement between the upper and lower parts of the rib cage and abdomen

    Measured: 5 minutes

Secondary outcomes (13)
  1. Forced Vital Capacity (FVC)

    Forced Vital Capacity (FVC) will be done with a spirometer according to the American Thoracic Society and European Respiratory Society criteria. The total amount of air (L) that can be forced out after taking a deep breath will be recorded. Measures lung capacity.

    Measured: Day 1

  2. Forced Expiratory Volume in 1 second (FEV1)

    Forced Expiratory Volume in 1 second (FEV1) will be done with a spirometer according to the American Thoracic Society and European Respiratory Society criteria. The amount of air (L) a person can forcefully expel in the first second of a breath will be recorded

    Measured: Day 1

  3. FEV1/FVC Ratio

    The percentage of the ratio of FEV1 to FVC will be calculated and recorded

    Measured: Day 1

  4. Forced Expiratory Flow 25-75% (FEF25-75)

    Forced Expiratory Flow 25-75% (FEF25-75%) will be assessed with a spirometer according to American Thoracic Society and European Respiratory Society criteria. The air flow rate (L/s) during the middle part of the exhalation (25%-75%) will be recorded.

    Measured: Day 1

  5. Peak Expiratory Flow (PEF)

    Peak Expiratory Flow (PEF) will be assessed with a spirometer according to American Thoracic Society and European Respiratory Society criteria. The highest flow rate (L/s) achieved during a forceful exhalation will be recorded.

    Measured: Day 1

  6. Breath Holding at Functional Residual Capasity

    If the duration is less than 25 seconds, it is considered as possible dysfunctional breathing

    Measured: 5 minutes

  7. Breath Holding at Total Lung Capacity

    If the duration is less than 35 seconds, it is considered as possible dysfunctional breathing

    Measured: 5 minutes

  8. Pain severity

    Visual analog scale (VAS) will be used in the assessment.Individuals' pain at rest, during activity and at night will be assessed on a scale of 0-10.Minimum score is 0 and maximum score is 10 Higher scores mean a worse outcome.

    Measured: 5 minutes

  9. Pain treshold

    For the assessment of pain threshold, the minimum pressure value that causes pain or discomfort will be recorded

    Measured: 10 minutes

  10. Pain tolerance

    the maximum tolerated pressure value will be recorded in the assessment of pain tolerance

    Measured: 10 minutes

  11. Beck Anxiety Scale

    The scale has 21 questions. The questions will be answered by selecting one of four options: none, mild, moderate and severe. 8-15 points will be categorized as mild anxiety symptoms, 16-25 points as moderate anxiety symptoms, 26 - 63 points as severe anxiety symptoms. the maximum score of the scale is 63

    Measured: 5 minutes

  12. EQ-5D-5L General Quality of Life Scale

    The scale has two parts. The first section has five sub-scales: movement, self-care, usual activities, pain/discomfort and anxiety/depression. The answers given in each section have 5 options; "no problem", "mild problem", "moderate problem", "severe problem" and "extreme problem". In the second section, individuals give a value between 0 and 100 about their current health status.

    Measured: 5 minutes

  13. Type D Personality Scale

    It consists of a total of 14 items and two subscales measuring negative affectivity and social inhibition. Each item is scored on a 0-4 scale. The cut-off point of the two subscales is ≥ 10.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2025
  2. Study start2 Feb 2025
  3. Primary completion2 Sep 2025 (estimated)
  4. Study completion2 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
54 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06992752
Sponsor's protocol ID
SBA-24/775
Status last verified
May 2025
First submitted
29 Apr 2025
Last updated
28 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: for patient data privacy

Questions about this trial

What is this clinical trial studying?

An observational study of Thoracic Outlet Syndrome, run by Hacettepe University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 28 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Melda Sağlam, Professor (+903123052525 ext. 146, msaglam@hacettepe.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nijmegen Questionnaire (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in